Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema

NCT02348918 PHASE2 COMPLETED Results posted

A Phase 2 Multi center, Randomized, Controlled, Double-Masked Clinical Trial Designed To Evaluate The Safety And Exploratory Efficacy Of Luminate® (Alg-1001) As Compared To Avastin® In The Treatment Of Diabetic Macular Edema

Details

Lead sponsor	Allegro Ophthalmics, LLC
Phase	PHASE2
Status	COMPLETED
Enrolment	218
Start date	Mon Oct 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Diabetic Macular Edema

Interventions

• Luminate 1.0mg
• Luminate 2.0mg
• Luminate 3.0mg
• Avastin
• Luminate 0.5mg

Countries

United States